Legend Biotech (LEGN) Cash from Discontinued Operations (2023 - 2024)

Legend Biotech (LEGN) has 5 years of Cash from Discontinued Operations data on file, last reported at 106286000.0 in Q1 2025.

• Quarterly Cash from Discontinued Operations fell 4558.31% year-over-year to 106286000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was 281625000.0 (down 104.54% YoY) and the FY2024 annual result came in at 144033000.0, up 63.38% from the prior year.
• Cash from Discontinued Operations slipped to 106286000.0 in Q1 2025, from 82078000.0 in the prior quarter.
• In the past five years, Cash from Discontinued Operations ranged from a high of 2384000.0 in Q1 2024 to a low of 106286000.0 in Q1 2025.
• A 3-year average of 70406250.0 and a median of 88861500.0 in 2023 frame the typical range for Cash from Discontinued Operations.
• Annual changes were most pronounced in 2024 — Cash from Discontinued Operations climbed 14.18% — and 2025, when it plunged 4558.31%.
• Tracing LEGN's Cash from Discontinued Operations over 3 years: stood at 95645000.0 in 2023, then advanced by 14.18% to 82078000.0 in 2024, then retreated by 29.49% to 106286000.0 in 2025.
• The last three Cash from Discontinued Operations figures came in at 106286000.0 (Q1 2025), 82078000.0 (Q4 2024), and 2384000.0 (Q1 2024), per Business Quant data.